Eline A M Zijtregtop
Overview
Explore the profile of Eline A M Zijtregtop including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
53
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zijtregtop E, Zeal J, Metzger M, Kelly K, Mauz-Koerholz C, Voss S, et al.
Blood Adv
. 2023 Jul;
7(20):6303-6319.
PMID: 37522740
The International Staging Evaluation and Response Criteria Harmonization for Childhood, Adolescent, and Young Adult Hodgkin Lymphoma (SEARCH for CAYAHL) seeks to provide an appropriate, universal differentiation between E-lesions and stage...
2.
Zijtregtop E, Winterswijk L, Beishuizen T, Zwaan C, Nievelstein R, Meyer-Wentrup F, et al.
Cancers (Basel)
. 2023 Feb;
15(4).
PMID: 36831520
While cervical lymphadenopathy is common in children, a decision model for detecting high-grade lymphoma is lacking. Previously reported individual lymphoma-predicting factors and multivariate models were not sufficiently discriminative for clinical...
3.
Zijtregtop E, Diez C, Zwaan C, Veening M, Beishuizen A, Meyer-Wentrup F
Br J Haematol
. 2022 Sep;
200(1):70-78.
PMID: 36128637
Classical Hodgkin lymphoma (cHL) is characterised by malignant Hodgkin Reed-Sternberg cells located in an inflammatory microenvironment. Blood biomarkers result from active cross-talk between malignant and non-malignant cells. One promising biomarker...
4.
Zijtregtop E, Tromp I, Dandis R, Zwaan C, Lam K, Meyer-Wentrup F, et al.
Pathol Oncol Res
. 2022 Aug;
28:1610482.
PMID: 36032657
Immunohistochemical markers are associated with treatment outcome in adults with classical Hodgkin Lymphoma (cHL). Studies in children are scarce and inconsistent. We investigated in 67 children with cHL, whether the...
5.
Zijtregtop E, Meyer-Wentrup F, Wong W, Hoogendijk R, Lopez-Yurda M, Zwaan C, et al.
EJHaem
. 2022 Jul;
1(1):152-160.
PMID: 35847691
Pediatric classical Hodgkin's lymphoma (cHL) is characterized by Hodgkin Reed-Sternberg cells located in an inflammatory microenvironment. Blood biomarkers result from active crosstalk between these cells. One promising biomarker in adult...
6.
Zhou Z, Hollink I, Bouman A, S Lourens M, Brooimans R, van Ham T, et al.
Pediatr Allergy Immunol
. 2022 Apr;
33(4):e13768.
PMID: 35470942
No abstract available.
7.
van Zogchel L, Lak N, Verhagen O, Tissoudali A, Gussmalla Nuru M, Gelineau N, et al.
JCO Precis Oncol
. 2021 Nov;
5.
PMID: 34820594
Methods: We developed a ddPCR assay to sensitively detect tumor-derived hypermethylated DNA in liquid biopsies. We tested this assay in plasma of 96 patients with neuroblastoma, renal tumors, rhabdomyosarcoma, or...
8.
Zijtregtop E, van der Strate I, Beishuizen A, Zwaan C, Scheijde-Vermeulen M, Brandsma A, et al.
Cancers (Basel)
. 2021 Mar;
13(4).
PMID: 33672548
Thymus and activation-regulated chemokine (TARC) is produced by different cell types and is highly expressed in the thymus. It plays an important role in T cell development, trafficking and activation...
9.
Reedijk A, Zijtregtop E, Coebergh J, Meyer-Wentrup F, Hebeda K, Zwaan C, et al.
Br J Haematol
. 2020 Feb;
189(6):1093-1106.
PMID: 32030738
Population-based studies that assess long-term patterns of incidence, major aspects of treatment and survival are virtually lacking for Hodgkin lymphoma (HL) at a younger age. This study assessed the progress...
10.
Zijtregtop E, Pijnenburg M, Rottier B, Duijts L
Ned Tijdschr Geneeskd
. 2012 May;
156(19):A4387.
PMID: 22571546
Background: Bronchiolitis obliterans is a non-reversible lung disease in which the inflammatory process ultimately leads to obstruction of the bronchioles. This condition often occurs after a lung or bone marrow...